XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100. A total of 29 filers reported holding XILIO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $207,223 | -12.3% | 218,705 | 0.0% | 0.00% | – |
| Q1 2024 | $236,201 | +96.4% | 218,705 | 0.0% | 0.00% | – |
| Q4 2023 | $120,288 | -73.9% | 218,705 | 0.0% | 0.00% | -100.0% |
| Q3 2023 | $461,468 | -19.5% | 218,705 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $573,007 | -17.6% | 218,705 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $695,482 | +18.2% | 218,705 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $588,316 | -7.5% | 218,705 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $636,000 | -0.5% | 218,705 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $639,000 | -58.7% | 218,705 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $1,546,000 | -55.8% | 218,705 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $3,499,000 | – | 218,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,441,444 | $4,195,000 | 4.87% |
| AJU IB Investment Co., Ltd. | 667,742 | $1,943,000 | 3.33% |
| Octagon Capital Advisors LP | 2,425,000 | $7,057,000 | 1.22% |
| Bain Capital Life Sciences Investors, LLC | 2,805,413 | $8,164,000 | 0.98% |
| Atlas Venture Life Science Advisors, LLC | 2,759,344 | $8,030,000 | 0.89% |
| Soleus Capital Management, L.P. | 453,660 | $1,320,000 | 0.18% |
| HARVARD MANAGEMENT CO INC | 416,059 | $1,211,000 | 0.15% |
| Rock Springs Capital Management LP | 1,362,878 | $3,966,000 | 0.10% |
| Artal Group S.A. | 450,000 | $1,310,000 | 0.06% |
| Cannell Capital | 17,025 | $50,000 | 0.01% |